Glassy-state stabilization of a dominant negative inhibitor anthrax vaccine containing aluminum hydroxide and glycopyranoside lipid A adjuvants
about
Development of a highly thermostable, adjuvanted human papillomavirus vaccine.Adjuvants in micro- to nanoscale: current state and future direction.Overview of Vaccine Adjuvants: Introduction, History, and Current Status.Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want
P2860
Glassy-state stabilization of a dominant negative inhibitor anthrax vaccine containing aluminum hydroxide and glycopyranoside lipid A adjuvants
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Glassy-state stabilization of ...... copyranoside lipid A adjuvants
@ast
Glassy-state stabilization of ...... copyranoside lipid A adjuvants
@en
type
label
Glassy-state stabilization of ...... copyranoside lipid A adjuvants
@ast
Glassy-state stabilization of ...... copyranoside lipid A adjuvants
@en
prefLabel
Glassy-state stabilization of ...... copyranoside lipid A adjuvants
@ast
Glassy-state stabilization of ...... copyranoside lipid A adjuvants
@en
P2093
P2860
P356
P1476
Glassy-state stabilization of ...... copyranoside lipid A adjuvants
@en
P2093
C Russell Middaugh
David B Volkin
John F Carpenter
Kimberly J Hassett
Lilia A Rabia
Megan C Cousins
Neha Sahni
Nishant K Jain
Sangeeta Joshi
Theodore W Randolph
P2860
P304
P356
10.1002/JPS.24295
P407
P577
2015-01-11T00:00:00Z